Skip to main content

Vaccination using different platforms encoding HER2-LAMP with heterologous boosting enhances adaptive HER2-specific immunity to enable potent anti-tumor responses

Publication ,  Conference
Marek, RD; Chen, A; Xu, R; Wei, J; Wang, T; Yang, X; Lei, G; Heiland, T; Hartman, ZC
Published in: CANCER RESEARCH
2022

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marek, R. D., Chen, A., Xu, R., Wei, J., Wang, T., Yang, X., … Hartman, Z. C. (2022). Vaccination using different platforms encoding HER2-LAMP with heterologous boosting enhances adaptive HER2-specific immunity to enable potent anti-tumor responses. In CANCER RESEARCH (Vol. 82).
Marek, Robert D., Alan Chen, Renhuan Xu, Junping Wei, Tao Wang, Xiao Yang, Gangjun Lei, Teri Heiland, and Zachary C. Hartman. “Vaccination using different platforms encoding HER2-LAMP with heterologous boosting enhances adaptive HER2-specific immunity to enable potent anti-tumor responses.” In CANCER RESEARCH, Vol. 82, 2022.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis